A €1bn Haircut, a Blocked Sale, and a Rival’s Advance: BayWa’s Restructuring Reaches Its Most Dangerous Phase

BayWa stock drops 34% amid 106% volatility, Agravis targets core market, T&G sale blocked by minority shareholder, threatening restructuring deadline.

BayWa’s stock is trading at €13.00, a level that reflects raw anxiety rather than rational price discovery. The shares have shed roughly 34% over twelve months, the annualised volatility sits above 106%, and the 200-day moving average of €15.84 remains a distant memory. A weekly gain of 4% looks more like a mechanical bounce than a vote of confidence, especially when the year-to-date deficit still stands at 22.4%.

The Munich-based agricultural conglomerate is not merely fighting a balance-sheet fire. It is also fending off a territorial assault while a minority shareholder in New Zealand blocks one of the most important asset sales in the restructuring playbook.

A Rival Sees an Opening

Agravis Raiffeisen AG, the cooperative-heavy player long dominant in northern and eastern Germany, is now targeting the south. CEO Dirk Köckler has identified the turmoil at BayWa as a chance to grab market share in a region that has been a core BayWa stronghold for decades.

The offensive focuses on wholesale supply of seeds, fertiliser and crop protection products, as well as the procurement of grains, maize and rapeseed. Agravis is deliberately avoiding BayWa’s other business lines — farm machinery, construction materials, heating oil — and zeroing in on the agricultural heartland.

This push arrives at a particularly delicate moment. A survey published in January by the Bayerisches Landwirtschaftliches Wochenblatt found that nearly half of the farmers polled no longer wanted to market their harvest through BayWa. CEO Dr. Frank Hiller’s departure at the turn of the year deepened the sense of uncertainty. Farmers who redirect their crop flows erode not just revenue but the decades-deep customer relationships that have sustained BayWa’s core franchise.

T&G: A ¥1.3bn Revival Blocked by a 20% Stake

Goldman Sachs has been mandated since March 2026 to sell BayWa’s 74% interest in T&G Global, the New Zealand-based marketer of the Envy and Jazz apple brands. T&G generated US$1.3bn in revenue in 2024 and swung to a net profit of US$16mn, making it an operationally healthy asset in a distressed portfolio.

The expected sale proceeds stand at roughly €300mn. The problem is the Joy Wing Mau Group, which holds just under 20% of T&G and is refusing to cooperate with the process. Unable to force a clean sale, BayWa watches a vital cash injection slip further away.

A T&G sale is one of three conditions that must be met by autumn 2026. The other two are the delivery of the audited 2025 annual report and the extension of the standstill agreement with core lenders DZ Bank and UniCredit/HVB. If any one of those conditions fails, the entire restructuring scaffolding could collapse.

The Plan A That Fell Apart

The original restructuring blueprint depended on selling a 51% stake in the renewable energy subsidiary BayWa r.e. at a projected €1.7bn. That plan is dead. The “One Big Beautiful Bill Act” in the United States eliminated federal subsidies for wind and solar projects, making BayWa r.e. all but unsaleable under current market conditions.

So far BayWa has raised approximately €1.3bn from completed divestments — Cefetra, RWA, WHG and EDL. That covers less than a third of the €4bn target set for 2028. The gap is enormous, and a 74% sale of T&G at €300mn would barely make a dent.

Creditors, Job Cuts and a Shrinking Footprint

The revised restructuring framework is expected to be finalised by mid-2026. Under the proposed terms, creditors would write off roughly €1bn. BayWa plans to cut around 1,300 jobs and reduce annual revenue to €10bn by 2028. Twenty-six of its approximately 400 locations are earmarked for closure by 2027.

The scale of creditor pain is already visible in the books of the Volks- und Raiffeisenbanken. They wrote down a €220mn promissory note by 60% in the last annual accounts, signalling that the haircut is not theoretical. Tensions between major shareholders and the banking syndicate over how the burden is shared continue to simmer.

Governance Overhaul and a Regulator’s Gaze

BayWa is also restructuring its supervisory board. The threshold for board approval of executive transactions has been slashed from €200mn to €50mn. Three new capital-side members are to be confirmed at the 2026 annual general meeting — a meeting that cannot take place until the fourth quarter at the earliest, because the 2025 consolidated financial statements are not yet available.

The external scrutiny does not stop there. Germany’s audit oversight body, Apas, is reviewing whether PricewaterhouseCoopers properly issued an unqualified audit opinion for the 2023 financial year. BayWa itself is examining potential damages claims against PwC and has already tendered the audit mandate for 2026 to another firm.

What the Autumn Brings

The coming months will test whether the new plan can do what the old one could not: rebuild credibility with banks, creditors and farmers simultaneously. The T&G sale must be unlocked, the audited accounts must be delivered, and the core banks must be persuaded to extend the standstill — all while Agravis courts the same customers that BayWa can least afford to lose. For a company whose stock is pricing in near-ruin, the harvest season is no longer just about crops. It is about survival.